Usefulness of pleural complement activation products in differentiating tuberculous and malignant effusions

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 1, 2000, Pages 76-82

  Porcel, J M ^a   Vives, M ^a   Gazquez I ^a   Vicente De Vera, M C ^a   Perez B ^a   Rubio, M ^a  

^a NONE

Author keywords

Complement activation; Malignancy; Pleural effusion; Tuberculosis

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5B;

AREA UNDER THE CURVE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; LUNG CANCER; MAJOR CLINICAL STUDY; PLEURA EFFUSION; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANAPHYLATOXINS; COMPLEMENT C3A; COMPLEMENT SYSTEM PROTEINS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PILOT PROJECTS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; ROC CURVE; TUBERCULOSIS, PLEURAL;

EID: 0033955082     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Light R W. Pleural diseases. 3rd ed. Baltimore: Williams & Wilkins, 1995.
2. Bothamley G H. Tuberculous pleurisy and adenosine deaminase. Thorax 1995; 50: 593-594.
3. Lew D P, Perrin L H, Vassalli J D, Suter S, Lambert P H, Waldvogel F A. High levels of complement breakdown products in tuberculous pleural effusions. Clin Exp Immunol 1983; 52: 569-574.
4. Hara N, Abe M, Inuzuka S, Kawarada Y, Shigematsu N. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions. Chest 1992; 102: 1060-1064.
5. Salomaa E R, Viander M, Saaresranta T, Terho E O. Complement components and their activation products in pleural fluid. Chest 1998; 114: 723-730.
6. Porcel J M, Peakman M, Senaldi G, Vergani D. Methods for assessing complement activation in the clinical immunology laboratory. J Immunol Methods 1993; 157: 1-9.
7. Bailar J C III, Louis T A, Lavori P W, Polansky M. A classification for biomedical research reports. In: Bailar J C III, Mosteller F, eds. Medical Uses of Statistics, 2nd Ed. Boston: NEJM books, 1992: 141-156.
8. Giusti G. Adenosine deaminase. In: Bergmeyer H U, ed. Methods of enzymatic analysis. New York: Academic Press, 1974: 1092-1099.
9. Hanley J A, McNeil B J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
10. Valdés L, Alvarez D, San José E, et al. Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax 1995; 50: 600-603.
11. Porcel J M, Vives M. El complemento en la inflamación. Rev Clin Esp 1996; 196 (Suppl 1): 13-18.
12. Porcel J M, Vergani D. Evaluación del complemento en el laboratorio. Rev Clin Esp 1996; 196 (Suppl 1): 19-25.
13. Ocaña I, Martínez-Vázquez J M, Segura R M, Fernández-de-Sevilla T, Capdevila J A. Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusions. Chest 1983; 84: 51-53.